Citation: P. Mullen et Sp. Langdon, The use of Matrigel in the establishment of ovarian carcinoma cell lines as xenografts, METH MOL M, 39, 2000, pp. 199-203
Authors:
Hendriks, HR
Fiebig, HH
Giavazzi, R
Langdon, SP
Jimeno, JM
Faircloth, GT
Citation: Hr. Hendriks et al., High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer, ANN ONCOL, 10(10), 1999, pp. 1233-1240
Authors:
Wilson, KE
Bartlett, JMS
Miller, EP
Smyth, JF
Mullen, P
Miller, WR
Langdon, SP
Citation: Ke. Wilson et al., Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines, BR J CANC, 80(5-6), 1999, pp. 685-692
Authors:
Simpson, BJB
Bartlett, JMS
Macleod, KG
Rabiasz, G
Miller, EP
Rae, AL
Gordge, P
Leake, RE
Miller, WR
Smyth, J
Langdon, SP
Citation: Bjb. Simpson et al., Inhibition of transforming growth factor alpha (TGF-alpha)-mediated growtheffects in ovarian cancer cell lines by a tyrosine kinase inhibitor ZM 252868, BR J CANC, 79(7-8), 1999, pp. 1098-1103